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Abstract
Pseudomonas aeruginosa infected peritoneal catheter exit sites have been a troublesome problem
among patients on continuous ambulatory peritoneal dialysis (CAPD). P. aeruginosa is characterized
by  its versatility and ability to colonize even in water with minimum nutrients. This is a retrospective
report on the experience of attempts to control the growth of the microbe by altering the acidity of
the habitat environment using diluted distilled white vinegar (pH 3). All patients were also treated
with oral ciprofloxacin. This regimen achieved 97% eradication with no relapse. The application of
vinegar dressing for P. aeruginosa infected peritoneal catheter exit sites was found to achieve an
apparently higher eradication and a lower relapse rate when compared with historical controls
using chlorhexidine or Eusol dressings. Further prospective study is required to confirm the
effectiveness of such regimen.
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INTRODUCTION
Exit site infection (ESI) has been a troublesome problem
among patients on continuous ambulatory peritoneal
dialysis (CAPD). Its definition, classification, choice of
antibiotic, treatment duration and timing for surgical
intervention are still controversial. However, it is
established that infections at the peritoneal catheter exit
site may contribute to many complications, including
tunnel infection, peritonitis and catheter loss, which may
ultimately require a change of treatment modality to
hemodialysis. One of the causative organisms for ESI is
Pseudomonas aeruginosa. This organism is characterized
by its versatility and its ability to colonize in water with
minimal nutrients,  as well as its ability to survive and
multiply over a broad temperature range of 20 oC to
42 oC (1). P. aeruginosa infected exit sites are not
uncommon in patients undergoing CAPD. It has been
reported that 10% to15% of ESI are infected with P.
aeruginosa. Research has suggested that this may be
related to the fact that Pseudomonas is a water-borne
bacterium that could invade the exit site during bathing
(2). It  has been reported that P. aeruginosa  ESI often
require catheter removal, although in a recent study,
treatment with oral ciprofloxacin 500 mg BD and local
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care resolved the infection in the majority of patients
(3).
From 1993 to 1997 in Tuen Mun Hospital, ESI is defined
in accordance with the cardinal signs of inflammation:
heat, redness, swelling and pain, in addition to the
features specific for an exit of any skin-penetrating
foreign body: purulent drainage, and regression of
epidermis with or without exuberance of granulation
tissue. Before a positive culture is confirmed, 0.05%
aqueous chlorhexidine is used to cleanse infected exits.
eusol (chlorinated solution of Lime and Boric acid
solution) is the other cleansing solution of choice for
exit sites with purulent discharge. A course of oral
antibiotics  is prescribed according to sensitivity results.
A retrospective study of the 168 cases of ESI encountered
during the period from May 1993 to August 1997 (4095
patient-months) revealed 29 patients had PA infection
(17%). The mean age of the PA infected group was
53 ±11.4 and the mean duration of CAPD treatment was
13.4 ±8.8 months. Nine of these patients were diabetics.
They were all treated with ciprofloxacin 500 mg P.O.
BD unless sensitivity results suggested otherwise. Ten
patients had a relapse of ESI despite adequate treatment.
Two of these patients were diabetic. Three patients
eventually developed tunnel infection and required
catheter removal at 4 to 11 months of initial infection.
The mean duration of treatment to achieve eradication
of the infection was 9.8 ±7.1 weeks.
Vinegar
A new nursing practice was introduced in our renal unit
with the aim to improve the outcome of PA ESI. When
we choose a cleansing agent, a non-irritating solution is
important (4). Environmental factor is essential for the
growth of microorganisms. Most bacteria demand
specific temperature for growth and they tend to grow
best at a pH of 6 to 8. Thus, an exit cleansing agent that
has a low pH, is non-irritating to the skin and does not
damage the peritoneal catheter is ideal. It has been found
that diluted (1:1) distilled white vinegar solution was
effective in the treatment of both gram-negative bacterial
wound infections and PA infected peritoneal catheter exit
sites (5-7). The acetic acid used can be made from
inexpensive distilled white vinegar (5% acetic acid,
Heinz Co. USA) (8), available in local supermarkets,
that can be diluted with sterile water for injection in 1:1
ratio. The pH of the final solution is 3, as compared to 7
for 0.05% chlorhexidine and 5 for Eusol. In order to
exclude the possible risk of the solution causing catheter
damage, peritoneal catheters were immersed in either
vinegar solution or 0.05% chlorhexidine for 7 days. There
was no visible distortion or destruction of the catheters
and no demonstrable leakage. All sample swabs taken
from the vinegar container for culture yielded no growth.
Vinegar dressing protocol
The usual dressing technique is used where sterile
applicator swabs are used in the from-inside-outwards
direction to clean the exit site, removing crusts and debris.
The exit site is air-dried before the application of a piece
of sterile gauze dressing. Vinegar dressing is to be
performed twice daily. Patients with PA ESI were
followed-up by their named nurses. A 2-week course of
ciprofloxacin 500 mg P.O. BD would be given unless
sensitivity results suggested otherwise. The named nurse
would closely follow the progress until the resolution of
ESI. The techniques of bathing, exit site care and exit
site dressing were reassessed. The change to the use of
vinegar dressing was explained to the patient and consent
was obtained. The nurse prepared the solution  by diluting
white vinegar with sterile water for injection (1:1)
aseptically in an autoclaved 30 mL Pyrex bottle  for 1-
day use. At the end of every 2 weeks: 1. If the exit site
was still wet with erythema, a swab would be taken for
culture while vinegar was continued; 2. If the exit site
became dry but erythema persisted, vinegar was
continued; 3. If it became dry without erythema, vinegar
would be discontinued. The patient would then be phone-
contacted once every 2 weeks for 1 month  to track the
exit site condition after successful treatment of the ESI.
METHOD
During the period from January 1998 to December 1999
(5442 patient-months), all CAPD patients with PA ESI
were recruited to use vinegar dressing when ESI persisted
Table 1.  Outcomes of PA ESI with Chlorhexidine/Eusol dressing and vinegar dressing.
Chlorhexidine/Eusol Dressing May 93 - Aug 97 (n = 29) Vinegar Dressing Jan 98 - Dec 99 (n = 38)
Sex (M:F) 19:10 15:23
Age (yr) 53.0 ±11.3 48.9 ±14.4
Dialysis duration (mo) 13.4 ±8.8 14.8 ±15.8
Renal disease (DM:non-DM) 9:20 13:25
Duration of treatment till eradication (wk) 9.8 ±7.1 5.1 ±2.8
Number of patients eradicated 26 (89%) 37 (97%)
Number of patients relapsed 10 0
Number of diabetic patients relapsed 3 0
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despite having been empirically on chlorhexidine 0.05%
or eusol dressing. All patients were followed-up by one
of three named nurses (DL, WM, EY).
Relapse of ESI was defined as recurrence of ESI by the
same organism within 4 weeks after completion of
antibiotics. The infection was defined as unresolved when
the positive culture and clinical signs persisted.
RESULTS
Results are shown in table 1. Thirty-eight patients with
PA ESI used vinegar dressing. There were 15 male and
23 female patients. The mean age of the patients was
48.9 ±14.4 (range 20-75), and the mean duration of
CAPD treatment was 14.8 ±15.8 (range 0-36) months.
Thirteen were diabetic. All patients tolerated and
accepted the solution and commented on the solution as
non-irritating. No skin irritation was noted and no
catheter damage was detected. Thirty-seven patients
(96%) were cured with no relapse of ESI after successful
treatment. Three patients required catheter removal: one
male non-diabetic patient with unresolved ESI developed
PA peritonitis at 14 weeks and required catheter removal;
a female patient developed acne over the face and body
when she was receiving androgenic hormones, then a
purulent discharging acne was formed at the skin surface
over the catheter tunnel at the third week after the exit
site had become dry; a third patient had catheter removal
for subcutaneous leaks, unrelated to the infection. The
infection was eradicated in all 13 diabetic patients. The
mean duration of vinegar dressing was 5.1 ±2.8 weeks.
DISCUSSION
The main aims of wound care are to promote wound
healing by appropriate integration with medical
intervention, to monitor progress of wound healing, and
to achieve the desired dry and clean healthy feature of
the wound. It is for these reasons that we tried vinegar
dressing in the management of PA ESI. The present study
on PA ESI revealed that the use of vinegar may shorten
the duration of therapy and reduce the relapse rate of
infection. The effort that the patients have made in
complying to the continuous self-healthcare is also
undeniable. While we are increasingly more cost-
conscious, the cost implication of relapsing ESI is
significant and the use of an inexpensive agent like
distilled white vinegar deserves further studies on its
microbiological action and clinical effects.
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